Related Experiment Video
Updated: Jul 15, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Patrick A Lewis1, Elisa Greggio, Alexandra Beilina
1Laboratory of Neurogenetics, National Institute on Aging, 35 Convent Drive, Bethesda, MD 20892-3707, USA.
Abstract:
Mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the leading genetic cause of Parkinson's disease (PD). LRRK2 is predicted to contain kinase and GTPase enzymatic domains, with recent evidence suggesting that the kinase activity of LRRK2 is central to the pathogenic process associated with this protein. The GTPase domain of LRRK2 plays an important role in the regulation of kinase activity. To investigate how the GTPase domain might be related to disease, we examined the GTP binding and hydrolysis properties of wild type and a mutant form of LRRK2. We show that LRRK2 immunoprecipitated from cells has a detectable GTPase activity that is disrupted by a familial mutation associated with PD located within the GTPase domain, R1441C.
Insights
Mutations in Leucine Rich Repeat Kinase 2 (LRRK2) cause Parkinson's disease (PD). A key PD-associated mutation (R1441C) disrupts the GTPase activity of LRRK2, impacting its function.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the primary genetic driver of Parkinson's disease (PD).
- LRRK2 possesses predicted kinase and GTPase enzymatic domains, with kinase activity implicated in PD pathogenesis.
- The GTPase domain is crucial for regulating LRRK2 kinase activity.
Purpose of the Study:
- To investigate the role of the LRRK2 GTPase domain in Parkinson's disease.
- To examine the GTP binding and hydrolysis properties of wild-type and mutant LRRK2.
Main Methods:
- Immunoprecipitation of LRRK2 from cellular samples.
- Assay of GTPase activity in immunoprecipitated LRRK2.
- Comparison of wild-type LRRK2 with a familial Parkinson's disease-associated mutant (R1441C).
Main Results:
- LRRK2 immunoprecipitated from cells exhibits measurable GTPase activity.
- The familial Parkinson's disease mutation R1441C, located in the GTPase domain, significantly disrupts this activity.
- This finding links altered GTPase function to LRRK2-associated Parkinson's disease.
Conclusions:
- The GTPase activity of LRRK2 is functionally relevant and can be impaired by disease-associated mutations.
- Disruption of LRRK2 GTPase function by mutations like R1441C may contribute to Parkinson's disease pathogenesis.
- Targeting LRRK2 GTPase activity could represent a therapeutic strategy for Parkinson's disease.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Lysosomal Hydrolases
Rab Cascades
Activation and Inactivation of G Proteins

